7HydroxyRAW Shutdown: Why Credit Card Processors Are Dropping 7-OH Products
Table of Contents
Why This Is Happening
Federal agencies including the FDA, DEA, and HHS have declared 7OH a dangerous synthetic opioid. Mastercard has issued BRAM violations to any processor supporting these transactions, with fines up to $500,000.
Official Shutdown Notice
7HydroxyRAW shared a public notice confirming their processor will no longer allow them to sell 7OH after Monday. They warned customers to order before Sunday night.
“We’ve officially been notified that our processor will no longer support the sale of 7-OH… We highly recommend ordering before Sunday night.”
“We’re doing everything we can to find a high-risk processor or crypto solution. Nothing is guaranteed.”
RawMIT Redirect & Payment Options
RawMIT.com now redirects to rawalx.com. The new site only offers PayPal and cryptocurrency payment options — a likely result of being dropped by their previous payment processor.
What the FDA and Mastercard Are Saying
- 7OH is a synthetically concentrated compound that does not naturally occur in kratom at retail levels
- It has been marketed as a dietary supplement in violation of FDA rules
- It carries opioid-like addiction potential, according to regulators
Key links:
Risks If You Don’t Comply
Avoid Processor Scams
Some payment agents may promise to continue processing for 7OH via miscoding or foreign banks. These setups are unsustainable and often end with MATCH placement or seizure of funds.
Full Letter From Processor
This letter serves to provide you with information concerning the sale of 7OH products and actions you must take to protect yourself and your business.
Recently, 7OH products have come under scrutiny by the FDA, HHS and DEA, as well as the American Kratom Association and several livestream webinars and press conferences have been held jointly by those organizations who maintain a current position that 7OH is an illegal synthetic drug and should be considered a dangerous opioid. The FDA and DEA are now considering 7OH a synthetic drug and an opioid and the full weight of the government is moving quickly to reschedule as a Class 1 drug and with enforcement actions to get these products removed from public access. The FDA has noted that many companies are selling 7OH as Kratom when it should not be considered Kratom. In concentrated form, 7OH is made synthetically and has dangerous opioid addiction qualities. 7OH has also been marketed as a dietary supplement in clear violation of FDA rules.
MasterCard has begun issuing BRAM violations for sale of products containing 7OH as an illegal drug and violation of MasterCard Brand standards.
The FDA and DEA are not going after the Kratom industry as a whole and have made particular note of some of the benefits of Kratom, which is still permitted to be sold by companies. They are solely focused on 7OH, where there is a lot of confusion as its often marketed as a form of Kratom; byproduct or Kratom; or naturally occurring substance of Kratom when in concentrated form…none of the above it true.
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers:
https://www.fda.gov/news-events/press-announcements/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers
Hiding in Plain Sight: 7-OH Products:
https://www.fda.gov/drugs/information-consumers-and-patients-drugs/hiding-plain-sight-7-oh-products
American Kratom Association 7OH:
RFK on combating 'dangerous opioid 7-OH:
On June 25, the FDA issued its first series of warning letters to merchants selling 7OH. This first series of warning letters appeared to target those marketing 7OH as a dietary supplement. However, the FDA has stated publicly that they plan on targeting any wholesalers, distributors and large merchants selling 7OH first in an effort to cut off the supply chain to retail stores.
MasterCard BRAM Violations:
As mentioned above, MasterCard has already begun sending out BRAM violation notices to merchants. It is important to understand that MasterCard fines for sale of illegal products or violation of their Brand Standards can carry fines upwards of $500,000.
You must discontinue sale of any remaining 7OH products no later than August 15, 2025. Please act as soon as possible given the enhanced enforcement actions currently taking place.
Be cautious of unethical agents offering to continue 7OH processing through misclassification or foreign setups. This will not work and will result in being fined or MATCH listed.
Letter Breakdown
- Key Enforcement Bodies: FDA, DEA, HHS, Mastercard
- Product Targeted: 7OH, not kratom
- Main Concerns: 7OH is synthetic, addictive, and misrepresented as natural
- Fines: $500,000+ per violation
- Deadline: August 15, 2025
Need Help Transitioning?
Request a Free Processing Review
We help brands safely pivot away from 7OH and stay compliant. Drop your email and we’ll reach out.
Final Thoughts
7OH processors are being terminated industry-wide. If you’re still selling 7OH, your account may be next. Take this seriously — compliance now prevents chaos later.
Don’t wait until your site is frozen or your funds are locked. Make the switch now.
Leave a Reply